Literature DB >> 23544179

Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study.

Mohammad U Qazi1, Shaista Malik.   

Abstract

The role of diabetes in the pathogenesis of cardiovascular disease (CVD) was unclear until 1979 when Kannel et al used data from the Framingham Heart Study (FHS) to identify diabetes as a major cardiovascular risk factor. It was also one of the first studies to demonstrate the higher risk of CVD in women with diabetes compared to men with diabetes. Since then, multiple studies have been done to recognize and curtail cardiovascular risk factors such as smoking, obesity, hypertension, hyperlipidemia, and insulin resistance. This review will examine the contribution of the Kannel article and subsequent studies in defining the contribution of several risk factors on cardiovascular disease.

Entities:  

Year:  2013        PMID: 23544179      PMCID: PMC3610922          DOI: 10.1016/j.gheart.2012.12.008

Source DB:  PubMed          Journal:  Glob Heart


  34 in total

1.  Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study.

Authors:  James B Meigs; Martin G Larson; Ralph B D'Agostino; Daniel Levy; Melvin E Clouse; David M Nathan; Peter W F Wilson; Christopher J O'Donnell
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

4.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; W D Rosamond; A R Sharrett; L E Chambless
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

5.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

6.  Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

Authors:  J I Barzilay; C F Spiekerman; P W Wahl; L H Kuller; M Cushman; C D Furberg; A Dobs; J F Polak; P J Savage
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

7.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

8.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study.

Authors:  J H Stengård; J Tuomilehto; J Pekkanen; P Kivinen; E Kaarsalo; A Nissinen; M J Karvonen
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more
  8 in total

1.  Relationship between high-sensitivity C-reactive protein and subclinical carotid atherosclerosis stratified by glucose metabolic status in Chinese adults.

Authors:  Haiyan Su; Yinghua Pei; Chunling Tian; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Hongmei Wu; Yang Xia; Xue Bao; Yeqing Gu; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Kun Song; Zhong Sun; Kaijun Niu
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

2.  Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.

Authors:  Zhihua Zheng; Junyan Wu; Ruolun Wang; Yingtong Zeng
Journal:  Funct Neurol       Date:  2014 Jan-Mar

3.  Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2016-12       Impact factor: 9.461

4.  Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males.

Authors:  Kelly Lum-Naihe; Ryan Toedebusch; Abuzar Mahmood; Jamal Bajwa; Terry Carmack; Senthil A Kumar; Sivakumar Ardhanari; Vincent G DeMarco; Craig A Emter; Lakshmi Pulakat
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

5.  Dietary Cholesterol Intake Is Not Associated with Risk of Type 2 Diabetes in the Framingham Offspring Study.

Authors:  Siyouneh Baghdasarian; Hsuan-Ping Lin; Richard T Pickering; Melanie M Mott; Martha R Singer; M Loring Bradlee; Lynn L Moore
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

6.  First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study.

Authors:  Pablo Miranda-Machado; Fernando Salcedo-Mejía; Justo Paz Wilches; Juan Fernandez-Mercado; Fernando De la Hoz-Restrepo; Nelson Alvis-Guzmán
Journal:  BMC Cardiovasc Disord       Date:  2019-01-08       Impact factor: 2.298

7.  Canagliflozin and cardiovascular outcomes in Type 2 diabetes.

Authors:  Ashish Sarraju; Gabriela Spencer-Bonilla; Fatima Rodriguez; Kenneth W Mahaffey
Journal:  Future Cardiol       Date:  2020-08-04

Review 8.  Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.

Authors:  Tarun Pant; Anuradha Dhanasekaran; Juan Fang; Xiaowen Bai; Zeljko J Bosnjak; Mingyu Liang; Zhi-Dong Ge
Journal:  BMC Cardiovasc Disord       Date:  2018-10-20       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.